Click and submit your question and we will get back to you within one business day
HiScript II Reverse Transcriptase is a new generation reverse transcriptase optimized from the M-MLV (RNase H-) Reverse Transcriptase. Compared with the last generation reverse transcriptase, the thermo-stability of this product is significantly improved. The half-life of HiScript II Reverse Transcriptase at 50℃ is >240 min. At 55℃, it can also be stable for a long time, which significantly benifits the transcription of RNA templates with complex secondary structure. In addition, it has a improved template affinity and cDNA synthesis efficiency. It has a good resistance to most RT-PCR inhibitors and is suitable for long-fragment cDNA amplification (as long as 20 kb).
Store at -30 ~ -15℃ and transport at ≤0℃.
Liu, Ning, et al. "Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11. 2 translocation renal cell carcinoma." Clinical and Translational Medicine 12.4 (2022): e797.Impact Factor:11.492
Raihan, Obayed, et al. "SRSF11 loss leads to aging-associated cognitive decline by modulating LRP8 and ApoE." Cell reports 28.1 (2019): 78-90.Impact Factor:9.423
Huang, Yujie, et al. "A systems pharmacology approach uncovers wogonoside as an angiogenesis inhibitor of triple-negative breast cancer by targeting hedgehog signaling." Cell chemical biology 26.8 (2019): 1143-1158.Impact Factor:8.116
Yan, Yi, et al. "Electron Transfer Flavoprotein (ETF) α Controls Blood Vessel Development by Regulating Endothelial Mitochondrial Bioenergetics and Oxygen Consumption." Oxidative medicine and cellular longevity 2022 (2022).Impact Factor:6.543